Anthrax continues to be uncommon in humans in Europe, with only a few cases reported every year. For 2020, three confirmed anthrax cases were reported by Italy. Twenty-eight EU/EEA countries notified zero confirmed cases.
As of 3 June 2022, 392 confirmed (n=370) and probable (n=22) cases of monophasic S. Typhimurium have been identified in the EU/EEA and the United Kingdom.
On 17 February 2022, the United Kingdom (UK) reported a cluster of cases with monophasic Salmonella Typhimurium sequence type 34 infection. As of 18 May 2022, 324 cases had been reported in 12 EU/EEA countries and the UK, including two distinct strains.
On 18 May 2022, ECDC and EFSA published an update of the rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
As of 19 April 2022, an outbreak of 187 confirmed and probable cases of monophasic S. Typhimurium (cluster 1) has been identified in the EU/EEA and the United Kingdom.
On 12 April 2022, ECDC and EFSA published a rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.
On 17 February 2022, the United Kingdom (UK) reported a cluster of cases with monophasic Salmonella Typhimurium sequence type 34 infection. By 8 April 2022, 150 cases had been reported in nine EU/EEA countries and the UK. Most cases are below 10 years of age and many children have been hospitalised.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 April 2022 and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, seasonal influenza, hepatitis, monophasic Salmonella Typhimurium, MERS-CoV, chikungunya and dengue.